Skip to main content

Find Clinical Trials

Home
Conditions
Disitamab Vedotin

Clinical trial condition

Disitamab Vedotin

Explore clinical trials studying Disitamab Vedotin. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Disitamab Vedotin trial results

Not Yet Recruiting

Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer

NCT07159217

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +7 more
Locations: Chinese Academy of Medical Sciences, Peking Union Medical College Hospital Beijing, China

View Trial Details

Not Yet Recruiting

RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations

NCT06185400

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Not specified

View Trial Details